Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Friedrich EG | Vaginitis. | 1985 | Am. J. Obstet. Gynecol. | pmid:3873872 |
Proost JM et al. | Miconazole in the treatment of mycotic vulvovaginitis. | 1972 | Am. J. Obstet. Gynecol. | pmid:4551031 |
Orley J | Nystatin versus boric acid powder in vulvovaginal candidiasis. | 1982 | Am. J. Obstet. Gynecol. | pmid:7148934 |
Van Slyke KK et al. | Treatment of vulvovaginal candidiasis with boric acid powder. | 1981 | Am. J. Obstet. Gynecol. | pmid:7282789 |
Diddle AW | Trichomonas vaginalis: resistance to metronidazole. | 1967 | Am. J. Obstet. Gynecol. | pmid:5182244 |
Culbertson C | MONISTAT: a new fungicide for treatment of vulvovaginal candidiasis. | 1974 | Am. J. Obstet. Gynecol. | pmid:4429114 |
Sanchez S et al. | Intravaginal metronidazole gel versus metronidazole plus nystatin ovules for bacterial vaginosis: a randomized controlled trial. | 2004 | Am. J. Obstet. Gynecol. | pmid:15592270 |
KAYSER HL et al. | The use of nystatin in the treatment of vaginal candidiasis in pregnancy. | 1957 | Am. J. Obstet. Gynecol. | pmid:13435297 |
Lee WM et al. | Refractory esophageal candidiasis associated with a low molecular weight plasma inhibitor of T-lymphocyte function. | 1986 | Am. J. Med. Sci. | pmid:3487248 |
Henry SA | Symposium on infectious complications of neoplastic disease (Part II). Chemoprophylaxis of bacterial infections in granulocytopenic patients. | 1984 | Am. J. Med. | pmid:6369979 |